ERBB2 and breast cancer: Similarly, in breast cancer cells [32] RE decreased expression of estrogen receptor α (ERα) in the ER+ subtype and human epidermal growth factor receptor 2 (HER2) in the HER2+ subtype, and it was suggested the decreased receptor expression was correlated with enhanced apoptosis in these cell subtypes.